mTOR在B细胞淋巴细胞恶性瘤中的作用:生物和治疗方面
Eleni A Karatrasoglou1, Maria Dimou2, Alexia Piperidou2
1First Department of Pathology, National and Kapodistrian University of Athens, Laikon General Hospital, 15773 Athens, Greece.
International journal of molecular sciences
|September 28, 2023
概括
拉巴胺素 (mTOR) 途径的酸3-激酶 (PI3K) /Akt/哺乳动物点驱动B细胞淋巴瘤. 这篇评论探讨了PI3K/Akt/mTOR的研究.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 血液学 血液学 血液学
背景情况:
- 非霍奇金淋巴瘤 (NHL) 的发病率正在增加,B细胞淋巴瘤是最常见的.
- PI3K/Akt/mTOR通路对于细胞增殖和存活至关重要,并且与淋巴发育有关.
- 这一途径在各种B细胞淋巴瘤中经常受到失调.
研究的目的:
- 在B细胞NHL中审查PI3K/Akt/mTOR通路的瘤机制.
- 专注于扩散大B细胞淋巴瘤 (DLBCL) 和地幔细胞淋巴瘤 (MCL).
- 总结mTOR抑制剂在B细胞NHL中的临床应用.
主要方法:
- 在B细胞淋巴瘤中PI3K/Akt/mTOR通路的文献综述.
- 在B细胞NHL临床试验中对mTOR抑制剂 (temsirolimus,everolimus) 的研究分析.
- 专注于常见的B细胞淋巴瘤类型,如DLBCL和MCL.
主要成果:
- PI3K/Akt/mTOR通路是B细胞淋巴发育的一个关键驱动因素.
- 在B细胞NHLs的临床试验中评估了mTOR抑制剂.
- 这些抑制剂显示出作为单一疗法或组合疗法的潜力.
结论:
- 针对PI3K/Akt/mTOR通路是B细胞NHL治疗的一个有希望的策略.
- 对于患有B细胞恶性瘤的患者来说,mTOR抑制剂是一个可行的治疗选择.
- 对组合疗法的进一步研究可能会提高治疗疗效.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:27Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K